GSK Seeks To Up Stake In Indian Unit By $1B
GlaxoSmithKline PLC on Monday offered to spend approximately $1 billion to increase its stake in its publicly listed pharmaceuticals subsidiary in India, GlaxoSmithKline Pharmaceuticals Ltd., from 50.7 to up to 75...To view the full article, register now.
Already a subscriber? Click here to view full article